![Avinash Desai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Avinash Desai is Chief Medical Officer at Actinium Pharmaceuticals, Inc. from 2021 to 2025.
Former jobs include Vice President-Global Medical Affairs at Eli Lilly & Co. and Vice President & Head-US Medical Affairs at Glaxo Smith Kline Biologicals NA.
Anciens postes connus de Avinash Desai
| Sociétés | Poste | Fin |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Directeur des opérations | 23/09/2021 |
| ELI LILLY AND COMPANY | Directeur Technique/Scientifique/R&D | - |
Glaxo Smith Kline Biologicals NA
 Glaxo Smith Kline Biologicals NA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Glaxo Smith Kline Biologicals NA
Glaxo Smith Kline Biologicals NA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
